Uncategorised - European Medical Journal

Why No Ideal Sepsis Tool Exists

Sepsis remains a medical emergency, but a new narrative review finds that no single screening tool reliably diagnoses it.

Retifanlimab Improves Survival in Metastatic Lung Cancer Trial

A phase 3 trial found that retifanlimab plus chemotherapy significantly improved survival in patients with metastatic NSCLC, with a safety profile consistent with other PD-1 inhibitors.

Microwave ablation, thyroid

Microwave Ablation Effective for Benign Thyroid Nodules

Microwave ablation is a safe, effective treatment for benign thyroid nodules and AFTNs.

New Algorithm Forecasts NSAID Efficacy for Knee Pain

Machine learning models can accurately predict which patients with painful knee osteoarthritis will benefit from short-term NSAID plus paracetamol therapy, according to new research.

Diabetes Not a Barrier for PCI with Orbital Atherectomy

Coronary orbital atherectomy is safe and effective for severe heart disease, even in patients with diabetes, real-world study shows.

Supersized US Drinks and Salty Snacks Flag Health Concerns

In a first-of-its-kind cross-national assessment, researchers compared the nutritional content and “healthiness” of sweet and salty snacks and beverages in South Korea and the United States using standard nutrition labels.

Can Biologic Therapy Be Safely Used in HS?

Adalimumab use in patients with hidradenitis suppurativa (HS) appears safe with appropriate prophylaxis, as no cases of hepatitis B virus (HBV) or tuberculosis (TB) reactivation were observed in a large retrospective analysis.

mutation

TP53 Mutations Reshape the Lung Adenocarcinoma Tumour Microenvironment

Study reveals how TP53 mutations alter lung adenocarcinoma tumour microenvironment, influencing progression and immunotherapy response.

Maternal Mediterranean Diet and Food Allergy Prevention

Food allergies are now considered the “second wave” of the allergy epidemic, following asthma, and they disproportionately affect infants and young children.

GLP-1RA, Lupus

GLP-1RA Shows Cardiovascular and Kidney Benefits in Lupus

GLP-1RA use lowered cardiovascular, kidney, and mortality risks in patients with lupus and diabetes